Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2011) K. Fizazi et al.   ANNALS OF ONCOLOGY

Adjuvant therapy in colon cancer

(2011) Janet S Graham et al.   Expert Review of Anticancer Therapy

Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study

(2010) Anne Kirstine Hundahl Møller et al.   ACTA ONCOLOGICA

Safety and Efficacy of a Combination of Docetaxel and Cisplatin in Patients With Unknown Primary Cancer

(2010) Hirofumi Mukai et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Paclitaxel/Carboplatin/Etoposide Versus Gemcitabine/Irinotecan in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site

(2010) John D. Hainsworth et al.   CANCER JOURNAL

NICE issues guidance on cancer of unknown primary

(2010) Norra MacReady   LANCET ONCOLOGY

Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: Multiple-treatments meta-analysis

(2009) Vassilis Golfinopoulos et al.   CANCER TREATMENT REVIEWS

Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis

(2009) Antoine Adenis et al.   INVESTIGATIONAL NEW DRUGS

Paclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary Site

(2009) J. D. Hainsworth et al.   ONCOLOGIST

Treatment for Patients With Unknown Primary Carcinoma and Unfavorable Prognostic Factors

(2009) F. Anthony Greco et al.   SEMINARS IN ONCOLOGY

Phase II Trial of Capecitabine and Oxaliplatin in Patients with Adeno- and Undifferentiated Carcinoma of Unknown Primary

(2009) Katharina Schuette et al.   Oncology Research and Treatment

Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: A multicentre Hellenic Cooperative Oncology Group phase II study

(2008) George Pentheroudakis et al.   ACTA ONCOLOGICA

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

(2008) G Huebner et al.   BRITISH JOURNAL OF CANCER

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

(2008) K Yonemori et al.   BRITISH JOURNAL OF CANCER

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review

(2008) George Pentheroudakis et al.   CANCER TREATMENT REVIEWS